Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopaminergic Modulation of Declarative Memory in PD
NCT03151460Phase 4Completed
- Sponsor
- Fondazione Santa Lucia IRCCS
- Start
- Sep 2014
- Primary completion
- Apr 2016
- Countries
- 1
01
Overview
Phase 4, open-label trial in Parkinson's disease (PD) (2 arms), sponsored by Fondazione Santa Lucia IRCCS. Primary endpoint: Performance on cognitive task. Started Sep 2014; status: completed.
02
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03151460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03151460.